MINT-ARIPIPRAZOLE
MINT-ARIPIPRAZOLE
Approved
DIN Number
02483580
Drug Class
Human
Market Date
Apr 14, 2020
Company
HC
mint pharmaceuticals inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02483580
AIG Number0152514003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX12 ARIPIPRAZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
ARIPIPRAZOLEActive
Strength: 15 MG
Monograph: ARIPIPRAZOLE